lung cancer

Research in Review

Lymph Node Metastasis Predicts Prognosis for Late-State NSCLC

08/26/2016

JCP Editors

Lymph node stage may provide important prognostic information related to survival for patients with non-small cell lung cancer (NSCLC), according to a study published in the Journal of Thoracic Oncology. Guidelines...

Lymph...

08/26/2016

Journal of Clinical Pathways

Quiz

Friday Morning Quiz ‚Äì August 21-28

08/25/2016

JCP Editors

A study published in Science Translational Medicine found that the inhabitation of what oncogenic protein might possibly be a target for therapeutic benefit in patients with non-small cell lung...

A...

08/25/2016

Journal of Clinical Pathways

Research in Review

Scan-associated Distress Common and Problematic Among Patients With NSCLC

08/25/2016

JCP Editors

Scan-associated distress, a common problem among patients with non-small cell lung cancer (NSCLC), may negatively affect quality of life, according to a study published in the journal Lung Cancer. Commonly referred...

...

08/25/2016

Journal of Clinical Pathways

Research in Review

Better Survival With Lung Cancer Detected Through Scheduled Screening

08/23/2016

JCP Editors

Lung cancers detected after initial screenings have better survival than patients who have negative results at baseline and later test positive, according to a study published in Plos One. For their study, the...

Lung...

08/23/2016

Journal of Clinical Pathways

Research in Review

New Lung Cancer Biomarker Identified

08/22/2016

JCP Editors

Inhibition of oncogenic protein BMI1 may offer a therapeutic benefit for certain patients with lung cancer, according to the results of an analysis published in Science Translational Medicine. In a prior study,...

...

08/22/2016

Journal of Clinical Pathways

Research in Review

Immunotherapy Plus Chemotherapy Does not Improve SCLC Outcomes

08/05/2016

JCP Editors

The addition of ipilimumab to etoposide and a platinum agent failed to demonstrate improved survival in patients with extensive-stage small-cell lung cancer when compared with chemotherapy alone, a study published in...

The...

08/05/2016

Journal of Clinical Pathways

Research in Review

Chemotherapy Followed By Surgery Improves Lung Cancer Outcomes Compared With Chemoradiation Alone

07/26/2016

JCP Editors

Preoperative chemotherapy followed by resection may produce better survival outcomes than chemoradiation alone for patients with lung cancer, according to a study published in Medical Science Monitor. Current...

...

07/26/2016

Journal of Clinical Pathways

Research in Review

Radiotherapy Timing Affects Outcomes for Small-Cell Lung Cancer

07/23/2016

JCP Editors

Earlier or shorter delivery of thoracic radiotherapy in addition to planned chemotherapy my significantly improve 5-year overall survival, albeit with more acute toxicity, according to a study published in the Annals...

...

07/23/2016

Journal of Clinical Pathways

Research in Review

Better Screening May Eliminate the Need for Lung Cancer Surgery in Some Patients

07/22/2016

JCP Editors

A new, large-scale study has lent support to the recommendation that nonsolid nodules identified by CT (computed tomography) scans can be managed with annual screening rather than with invasive biopsies or...

A new,...

07/22/2016

Journal of Clinical Pathways

Research in Review

Second-line Treatment Option Identified for Small Cell Lung Cancer

06/23/2016

JCP Editors

A regimen containing cisplatin, etoposide, and irinotecan may be clinically beneficial as a second-line treatment for certain patients with small cell lung cancer, according to a clinical trial conducted in...

A...

06/23/2016

Journal of Clinical Pathways